# Nuclide record scott-tagawa (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/scott-tagawa/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "scott-tagawa" ;
  schema:name "Scott T. Tagawa"@en ;
  schema:alternateName "Scott Tagawa"@en ;
  schema:description "A cancer doctor at Weill Cornell in New York who has spent two decades testing PSMA-targeted radioactive treatments for prostate cancer, from the first antibody versions through to lutetium-177 PSMA-617."@en ;
  schema:url <https://nuclide.cc/people/scott-tagawa/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://weillcornell.org/sttagawa>, <https://www.sciencedirect.com/science/article/pii/S0302283824000206> ;
  nuclide:tag "prostate", "PSMA", "clinician" ;
  schema:jobTitle "Professor of Medicine and Urology, and Director of the Genitourinary Oncology Program, Weill Cornell Medicine / NewYork-Presbyterian" ;
  nuclide:related <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/trials/vision/>, <https://nuclide.cc/isotopes/lu-177/> .